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Background
Five percent of colorectal cancers are attributable to
hereditary syndromes for which genetic testing is clini-
cally available. Effective surveillance strategies and risk-
reducing surgeries lower risk for people diagnosed with
inherited colorectal cancer syndromes. However, from a
public health standpoint, the existence of effective inter-
ventions is futile if not applied broadly and appropriately
to the population at risk. Efficient identification of peo-
ple with hereditary risk remains a challenge, and failure
to systematically identify people at high hereditary risk
results in preventable morbidity and mortality. The
William C. Bernstein M.D. Familial Cancer Registry
(Bernstein Registry) is a research-based program that
triages participants for hereditary cancer risk. Self-
reported family histories are assessed and participants
are given tailored information about their hereditary risk
factors. People at high risk are given information about
the availability and advisability of clinical genetics ser-
vices. Pilot populations are being enrolled to establish
registry processes and determine the feasibility of imple-
mentation at a population-based level. This pilot group
includes volunteers from a previously established color-
ectal cancer registry.
Materials and methods
A 7-item screening questionnaire determines potential
eligibility for the Bernstein Registry using elements of
early onset, multiple primary and family history of
cancers. Potentially eligible participants are contacted
by telephone and a four-generation cancer history is
generated via guided interview. Pedigrees are analyzed
by genetic counselors for hereditary cancer risk prob-
abilities based on published guidelines. Targeted, tai-
lored risk information is provided in writing along
with a copy of the family tree. A list of genetic coun-
seling service providers is included for people at high
risk.
Results
Four hundred sixty six (466) of 898 people (52%) in
the Minnesota Colorectal Cancer Initiative (MCCI)
registry have histories eligible for the Bernstein regis-
try. To date, 437 invitations have been mailed to this
group, 55% responded. Of 242 completed eligibility
screeners, 239 proved eligible (99%), and 155 (64%)
have enrolled. Of 55 completed assessments, 44 have
been classified as high risk, with genetic counseling/
testing recommended.
Conclusions
The Bernstein Registry can systematically determine
who may benefit from clinical genetics services
(genetic counseling and testing). A majority of indivi-
duals from families previously identified as high risk
are motivated to participate in research and tolerate
the relatively onerous enrollment process. Whether
this same population will follow through on recom-
mendations to pursue genetic counseling and testing,
and whether the intensive risk-identification process is
feasible and sustainable on a public health level is the
target of future research.
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